Segall Bryant & Hamill LLC Has $46.23 Million Stock Position in Ingevity Co. (NYSE:NGVT)

Segall Bryant & Hamill LLC lifted its stake in shares of Ingevity Co. (NYSE:NGVT) by 33.5% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,185,415 shares of the company’s stock after buying an additional 297,135 shares during the quarter. Segall Bryant & Hamill LLC’s holdings in Ingevity were worth $46,231,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of the stock. First Horizon Advisors Inc. increased its stake in Ingevity by 809.2% in the second quarter. First Horizon Advisors Inc. now owns 591 shares of the company’s stock valued at $26,000 after purchasing an additional 526 shares in the last quarter. Blue Trust Inc. grew its holdings in Ingevity by 101.8% during the second quarter. Blue Trust Inc. now owns 896 shares of the company’s stock worth $43,000 after buying an additional 452 shares in the last quarter. Headlands Technologies LLC bought a new position in shares of Ingevity during the second quarter valued at about $46,000. KBC Group NV boosted its stake in shares of Ingevity by 50.8% in the 3rd quarter. KBC Group NV now owns 1,574 shares of the company’s stock worth $61,000 after buying an additional 530 shares during the last quarter. Finally, nVerses Capital LLC purchased a new position in shares of Ingevity in the 3rd quarter worth about $113,000. Institutional investors own 91.59% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on NGVT shares. BMO Capital Markets raised their price target on shares of Ingevity from $40.00 to $47.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Oppenheimer cut their price target on Ingevity from $58.00 to $50.00 and set an “outperform” rating for the company in a report on Thursday, August 1st. Wells Fargo & Company lowered their price target on shares of Ingevity from $45.00 to $40.00 and set an “equal weight” rating on the stock in a report on Monday, August 5th. Finally, CJS Securities upgraded shares of Ingevity from a “market perform” rating to an “outperform” rating and set a $58.00 price target for the company in a research report on Wednesday, August 7th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $52.17.

Ingevity Trading Down 0.1 %

Shares of NGVT opened at $45.96 on Wednesday. The firm has a fifty day simple moving average of $38.84 and a two-hundred day simple moving average of $42.05. Ingevity Co. has a twelve month low of $30.90 and a twelve month high of $56.29. The stock has a market capitalization of $1.67 billion, a P/E ratio of -2.96 and a beta of 1.60. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 6.52.

Ingevity (NYSE:NGVT) last released its quarterly earnings results on Tuesday, October 29th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.50. The company had revenue of $376.90 million for the quarter, compared to analyst estimates of $376.95 million. Ingevity had a positive return on equity of 24.46% and a negative net margin of 38.11%. The firm’s revenue was down 15.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.21 earnings per share. On average, research analysts anticipate that Ingevity Co. will post 2.55 EPS for the current year.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.